Association of outpatient use of renin–angiotensin–aldosterone system blockers on outcomes of acute respiratory illness during the COVID-19 pandemic: a cohort study

Molly Moore Jeffery,Lucas Oliveira J E Silva,Vesna D Garovic,Fernanda Bellolio,Andrew Limper,Timothy M Dempsey,Nathan W Cummins

doi:10.1136/bmjopen-2021-060305

Association of outpatient use of renin–angiotensin–aldosterone system blockers on outcomes of acute respiratory illness during the COVID-19 pandemic: a cohort study

Molly Moore Jeffery, Lucas Oliveira J E Silva + Show 5 more

Open Access

https://doi.org/10.1136/bmjopen-2021-060305

Copy DOI

Journal: BMJ open	Publication Date: Jul 1, 2022
Citations: 4	License type: open-access

Affiliation: Mayo Clinic, Optum (United States), David Grant USAF Medical Center, Grant Medical Center

#Risk Of Acute Respiratory Distress Syndrome #Acute Viral Respiratory Illness + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

ObjectivesEvaluate the associations between patients taking ACE inhibitors and angiotensin receptor blockers (ARBs) and their clinical outcomes after an acute viral respiratory illness (AVRI) due to COVID-19.DesignRetrospective cohort.SettingThe USA; 2017–2018...

Full Text